**Question:** Haemopoietic malignancy is seen in

A. Lymphatic system
B. Myeloid system
C. Bone marrow
D. Platelet disorders

**Correct Answer:** B. Myeloid system

**Core Concept:** Haemopoietic malignancy refers to a group of blood-related cancers that originate from the hematopoietic stem cells, which are responsible for producing blood cells. These cells can differentiate into various blood cell types, including erythrocytes, leukocytes, and platelets. Haemopoietic malignancies are classified into two main types: lymphoid and myeloid malignancies.

**Why the Correct Answer is Right:** Myeloid malignancies arise from the myeloid lineage of hematopoietic stem cells, which is part of the myeloid system. The myeloid system is responsible for producing neutrophils, eosinophils, basophils, monocytes, and platelets. The correct answer (Myeloid system) is right because it encompasses the origin of myeloid malignancies.

**Why Each Wrong Option is Incorrect:**

A. Lymphatic system (Option A) is incorrect because lymphoid malignancies, not myeloid malignancies, are associated with the lymphatic system. Lymphoid malignancies produce lymphocytes, which are involved in immune responses, while myeloid malignancies produce neutrophils, eosinophils, basophils, monocytes, and platelets.

B. Platelet disorders (Option D) are not considered haemopoietic malignancies. Platelet disorders primarily involve abnormalities in platelet production or function, such as thrombocytopenia or thrombocytosis, but they do not represent cancers of hematopoietic stem cells.

C. Bone marrow (Option C) is a site where blood cell production occurs, but it does not define the type of malignancy. Haemopoietic malignancies can arise from the bone marrow or other hematopoietic tissues, but the correct answer is "Myeloid system," as it represents the lineage of cells affected by these malignancies.

**Clinical Pearl:** A thorough understanding of the myeloid system and lymphoid system is crucial for diagnosing and treating haemopoietic malignancies. Accurate classification of these malignancies into lymphoid and myeloid categories is essential for appropriate treatment strategies and prognosis.